Shear-wave methods (SW) by ultrasound or magnetic resonance have been introduced for noninvasive measurements of myocardial shear elasticity (μ). Recent studies have shown a correlation between μ and left ventricular pressure (LVP) or contractility. How these factor interact, particularly in vivo, remains unclear. Stiffness increases due to several factors, from active contraction to passive stretch, changes with disease, and so on. We studied whether there is a unique μ-LVP relationship in vivo in active vs. passive state. Methods: μ of anterior LV myocardium was measured in 10 pigs by 2 methods, the SW method (SDUV) and from classical stress-strain relationships (sonomicrometry and pressure data). In 5 animals, a reperfused MI was induced. The active (systole) and passive (volume loading) μ-LVP relations in the same animal were compared. Results: In all animals, there was a linear relationship between μ and LVP during the heart cycle (left Figure) , regardless of whether the myocardium was normal or infarcted (R 2 : 0.84±0.10 in 10 normal animals and 0.87±0.14 in 5 animals with MI; P<0.05). The slopes of these relations tended to be lower post-MI. In MI, μ was higher at end-diastole (P<0.05) but pseudo-normal during systole. The reconstructed μ-LVP relations indicated that, at the same LVP, μ was higher in contracting myocardium vs. the passive state (right Figure) . Conversely, relationships were similar in MI (right Figure) . Animals with small subendocardial infarcts had more complex pattern.
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Purpose: The diagnostic accuracy of myocardial contrast echocardiography (MCE), performed during stress echocardiography (SE), for evaluation of known or suspected coronary artery disease (CAD), has been proven in research studies. However, the feasibility and value of MCE incorporated into a real-world clinical SE service are unknown. This prospective study thus aimed to determine the clinical role of MCE. Methods: All patients had been referred for SE on clinical grounds. We performed MCE during SE, using a continuous infusion of Sonovue contrast, in patients undergoing pharmacological stress and those performing exercise in whom we suspected a high workload or target heart rate may not be attained. We documented clinical and SE variables and value of MCE to the reporting cardiologist, predefined as: incremental benefit over wall motion (WM), more confidence with WM, no benefit over WM or uninterpretable MCE images. All studies were analysed by the performing cardiologist and an expert. We examined agreement between WM and MCE data and angiography findings, where significant CAD was defined as ≥50% stenosis. Purpose: Patients with chest pain and unobstructed coronary arteries have an increased adverse cardiovascular outcome compared to those with normal coronary arteries. The aetiology is unclear but may be due to coronary microvascular dysfunction. In the largest study to date, we studied the relationship between risk factors (RF) for coronary disease (CD) and myocardial blood flow (MBF) in patients with chest pain and unobstructed coronary arteries. Methods: We recruited patients with chest pain and low or intermediate probability for CD, to undergo CT coronary angiography (CTCA). Those with either mild stenosis on CTCA or, moderate stenosis and normal functional imaging, had myocardial contrast echocardiography (MCE) at rest and during dipyridamole stress. MBF baseline (MBFb), stress (MBFs) and MBF reserve (MBFR) was obtained. High-sensitivity CRP (hs-CRP), arterial stiffness index (ASI) and carotid intimamedia thickness (IMT) were measured. Results: 205 patients, mean age of 60±9.7 (range 32 -81) years and 108 (53%) male were studied. Multiple regression analysis demonstrated the following to be significant independent predictors of reduction in MBF. Specifically, for each decade increase in age there was a 14% (p<0.05) reduction in MBFs. Male gender was associated with a reduction in MBFb and MBFs by 11% (p<0.005) and 14% (p<0.001), respectively. Diabetes reduced MBFs by 17% (p<0.01), and for each 10 kg/m 2 increase in BMI there was a 9% (p<0.05) and 12% (p<0.005) reduction in MBFr and MBFs, respectively. Increase in total cholesterol by 1 mmol/L was associated with a 4% (p<0.05) reduction in MBFs. A 1 m/s increase in ASI correlated with a 2% (p<0.05) reduction in MBFb. Smoking was associated with a 7% (p<0.05) reduction in MBFs. A 10 mg/L increase in hs-CRP was associated with a 9% (p<0.05) increase in MBFb. IMT was not an independent predictor of MBF. Age was inversely associated with MBFR (p<0.05). Patients were divided into 3 groups according to number of RF: group A <3 RF, group B 4-6 RF, group C >6 RF. Between groups comparison indicated increasing RF was cumulatively associated with a reduction in MBFb: group A 32.5±7.0 dB 2 /s, group B 29.5±7.2 dB 2 /s, group C 26.6±6.0 dB 2 /s (p<0.01), and also MBFs: group A 69.8±13.7 dB 2 /s, group B 59.2±15.7 dB 2 /s, group C 52.0±14.7 dB 2 /s (p<0.001). There was no significant relationship with MBFR (group A 2.3±0.4, group B 2.2±0.5, group C 2.1±0.5).
Conclusion:
In patients with chest pain and unobstructed coronary arteries, MBF is significantly affected by risk factors for CAD. This effect is more pronounced as the number of risk factors increase.
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Coronary artery disease extent, severity and risk among active smokers, past smokers and non-smokers: a prospective study of 13,372 patients undergoing coronary CT angiography Objective: Although smoking is an established risk factor for major cardiac adverse events (MACE), the relative risk of current versus past smoking is poorly understood. We evaluated coronary artery disease (CAD) extent, severity and risk of MACE for active smokers and past smokers undergoing coronary CT angiography (CCTA). Methods: From a prospective multicenter international study, we enrolled patients without known CAD who underwent CCTA [2853 current smokers (21%); 3175 past smokers who quit >3 months prior to CCTA (24%); and 7344 non-smokers (55%)]. By risk-adjusted Cox proportional hazards models, adjusting for age, gender, risk-factors, segment involvement score, ≥50% stenosis, we related smoking status to incident risk of MACE, as defined by death, myocardial infarction or unstable angina. We further performed 1:1:1 propensity matching for 1000 current smokers, past smokers and non-smokers each to evaluate MACE risk amongst Imaging in ischaemic heart disease / Congenital heart disease -interventional and surgical issues 367 individuals who were of similar age, gender, CAD risk factors and symptom presentation. Results: 13372 patients (56.2±12.8 years, 51% male) were followed for 2.0±0.9 years follow-up, with 279 (2.1%) MACE occurring. Compared to non-smokers, current and past smokers had higher prevalence of obstructive CAD (≥50%) [1-vessel disease (VD); 11.2% vs. 16.6% vs. 16.2%, p<0.001, 2VD; 4.8% vs. 7.3% vs. 7.8%, p<0.001, 3VD; 2.3% vs. 5.1% vs. 5.0%, p<0.001]. Current smokers experienced higher risk of MACE compared to non-smokers (HR 1.9, 95% CI 1.4-2.5, p<0.001), while past smokers did not (HR 1.2, 95% CI 0.9-1.6, p=0.29). Even amongst matched individuals, current smoking was associated with MACE risk (HR 2.3, 95% CI 1.2-4.4, p=0.01), while past smoking was not (HR1.0, 95% CI 0.5-2.1, p=0.98). Conclusion: While both current and past smokers possess a greater prevalence, extent and severity of CAD compared to non-smokers, current smokers experience higher risk of MACE than past smokers and non-smokers.
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Myocardial perfusion scintigraphy (Gated-SPECT) in patients with ischemic ST-segment only during recovery phase of the exercise testing 
Purpose:
The ST-segment depression occurring only in the recovery phase (↓STr) is relatively rare and occurs in 1-3% of the exercise testing (ET). The diagnostic and prognostic value is less investigated as compared with that observed during exercise. Only few studies have investigated the clinical significance of this finding. Objective: The aim of this study was evaluate the association between the ↓STr of the ET with the gated-SPECT imaging alterations. Methods: We analyzed 92 patients with ↓STr (≥ 1 mm), who underwent gated-SPECT associated with ET and Bruce protocol, mean age 60±9.9 years, 74 (80.4%) male, with previous coronary artery bypass graft in 20%, myocardial infarction in 25%, and percutaneous coronary intervention in 35.2%. Qualitative analysis of imaging used 5-point score (0-normal; 4-no uptake) for perfusion (17 myocardial segments), and 6-point score (0-normal; 5-diskinesia) for motility. Left ventricular ejection fraction (LVEF) was assessed after ET. ↓STr, blood pressure (BP), heart rate (HR), time of tolerance to exercise (TTE), functional capacity (MET), appearance time to ↓STr (AT↓STr), and presence of arrhythmias were evaluated during ET. Results: Abnormal perfusion was observed in 58 patients (63.04%), 50% with isolated ischemia or associated with persistent defect; abnormal motility in 31 patients (33.7%) and mean LVEF of 57.8±11.6%. AT↓STr 202±38 sec, magnitude of ↓STr 1.2±0.3 mm, 10.4±2.7 MET; angina in 16pts (17.6%) and ventricular arrhythmias in 58 pts (63%). There were significant differences in the association between perfusion alterations with: male p = 0.000, positive predictive value (PPV) 73%; AT↓STr p = 0.011, PPV 76.2%; increase in systolic blood pressure ≤ 30mmHg during ET p = 0.002, PPV 91.3%; and typical angina p = 0.025, PPV 87.5%. In patients with only transient defect, there were significant differences for male (p = 0.01), hypertension (p = 0.04) and marginal significance when systolic blood pressure ≤ 30mmHg (p = 0.09). The PPV of ↓STr to any perfusion, motility or LVEF alteration was 64%. Conclusion: ↓STr of the ET occurred late, and was a relevant finding due to the high incidence of documented alterations in the gated-SPECT. Purpose: Fractional flow reserve (FFR) at the time of invasive coronary angiography (ICA) is the gold standard for determining lesion-specific ischemia, and identifies ischemia in a significant proportion of lesions considered anatomically non-obstructive. Beyond luminal stenosis severity, coronary CT angiography (CT) enables evaluation of atherosclerotic plaque characteristics (APCs) that include positive remodeling (PR), low attenuation plaque (LAP) and spotty intra-plaque calcification (SC). The relationship of these APCs to ischemia in non-obstructive coronary lesions has not been evaluated to date. Methods: 252 patients from 17 centers in 5 countries were prospectively enrolled. Patients underwent CT and ICA, with clinically indicated FFR performed for 407 coronary lesions. CTs were evaluated by an independent core laboratory in blinded fashion, with ≥50% and <50% stenosis considered obstructive and non-obstructive, respectively. Presence of APCs within coronary lesions by CT was defined as: (1) PR, maximal lesion diameter/reference diameter ≥1.10; (2) LAP, any intra-plaque voxel <30 HU; and (3) SC, nodular calcified plaque ≤3 mm. Coronary lesion-specific ischemia was defined by an FFR ≤0.8.
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Results:
For FFR-interrogated coronary lesions, 195 of 407 (48%) were nonobstructive by CT. FFR-defined ischemia was present in 33 of 195 (17%) lesions, with a mean FFR value of 0.75±0.07. Amongst non-obstructive lesions that caused ischemia, 24 (73%), 9 (27%) and 8 (24%) exhibited PR, LAP and SC, respectively; with at least 1 APC present in 24 (73%) of lesions. In multivariable analyses, the presence of PR [Odds ratio (OR) 6.6, 95% confidence interval (CI) 2.4-17.9, p<0.0001)] was associated with lesion-specific ischemia while LAP (OR 1.0, 95% CI 0.3-3.2, p=0.9) and SC (OR 1.4, 95% CI 0.5-4.5, p=0.5) were not. A dose-response relationship was observed for increasing risk of ischemia for non-obstructive coronary lesions possessing 1 (OR 4.5, p=0.006), 2 (OR 11.8, p<0.001) and 3 (OR 4.0, p=0.1) APCs.
Conclusion:
The presence of positive arterial remodeling and increasing numbers of APCs enhances diagnosis of non-obstructive coronary lesions that cause ischemia.
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Four-year outcomes of a coronary computed tomography angiography-guided strategy for chest pain evaluation in the emergency department A. Nasis, I.T. Meredith, P. Sinha, J.D. Cameron, S.K. Seneviratne. Monash Heart, Melbourne, Australia Purpose: We sought to determine the long-term safety of a novel diagnostic approach that utilised coronary computed tomography angiography (CTA) to assess patients presenting to the Emergency Department (ED) with low-to-intermediate risk chest pain. Methods: We prospectively evaluated 585 consecutive patients who presented to ED between September 2008 and June 2011 with low-to-intermediate risk (TIMI 0-4) ischaemic-type chest pain who were evaluated with 320-row CTA after normal electrocardiogram and negative single (284 patients) or serial troponin (301 patients) depending on time of presentation. Patients with previous significant coronary stenoses or revascularisation were excluded. Patients undergoing CTA after single troponin who had no plaque on CTA were discharged without serial troponin and no further investigation following discharge. Patients undergoing CTA after single troponin who had any plaque and up to mild stenoses were discharged after repeat troponin with no further investigation following discharge. Patients with moderate stenoses were discharged with outpatient stress echocardiography. Patients with severe stenoses were admitted for invasive angiography. Discharged patients were contacted by telephone and medical records reviewed to determine safety outcomes. Results: Mean age was 58±11 years (58% male). 93/284 patients (33%) undergoing CTA after single troponin had no plaque and were discharged after only a single troponin. 486/585 patients overall (83%) had no plaque or mild stenoses on CTA and were discharged with no further investigation, 24/585 (4%) had moderate stenoses on CTA and were discharged with outpatient stress echocardiography and 74/585 (13%) had severe stenoses on CTA and were admitted for invasive angiography. At median 47.1-month follow-up (range 20-53 months), there had been five chest pain readmissions (1%, 95% confidence interval 0.4-2.3%), no revsascularisation procedures, no myocardial infarctions and no deaths (95% confidence interval 0-0.8%). Follow-up was 99% complete. Conclusion: Triaging low-to-intermediate risk patients with a CTA-guided strategy is safe at long-term follow-up, including patients discharged after a single negative troponin. Purpose: Transcatheter closure of peri-membranous ventricular septal defects (pmVSDs) has been associated with a significant risk of complete heart block, leading most groups to abandon the technique. We describe the initial world experience of pmVSD closure with a newly designed occluder. Methods: Patients with pmVSD underwent catheter closure using the Amplatzer ® Membranous VSD Occluder 2 (St. Jude Medical, MN, USA). Results: Nineteen patients from the 4 centers initially involved worldwide were prospectively included and followed for a 12±3 months. Patients ranged in age from 1.4 to 62 years (median 6 years) and in weight from 9.3 to 96 kg (median26 kg). The Qp/Qs ratio was (mean ± SD) 1.9±1.6. The size of the defect on left ventricular side was (mean ± SD) 9.9±3.5 mm (range 4.6 -16 mm) and the orifice on right ventricularside was 8.1±2.8 mm (range 3.9 -14 mm) by echocardiography. Mean device size was 9.4±2.4 mm (range 5 -14 mm). An eccentric device was used in 9 patients (47%) and a concentric device in 10 (53%). A device was suc-
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